These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9634335)

  • 1. Once weekly ganciclovir as prophylaxis is unacceptable to patients.
    Bibby K; Rosenthal AR; Nicholson KG; Wiselka MJ
    Sex Transm Infect; 1998 Apr; 74(2):160-1. PubMed ID: 9634335
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of daily versus three-times-weekly prophylactic ganciclovir after lung and heart-lung transplantation.
    Hertz MI; Jordan C; Savik SK; Fox JM; Park S; Bolman RM; Dosland-Mullan BM
    J Heart Lung Transplant; 1998 Sep; 17(9):913-20. PubMed ID: 9773865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.
    Palmer SM; Grinnan DC; Diane Reams B; Steele MP; Messier RH; Duane Davis R
    Clin Transplant; 2004 Apr; 18(2):179-85. PubMed ID: 15016133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir prophylaxis for CMV disease infrequently associated with viral resistance.
    AIDS Patient Care; 1995 Dec; 9(6):308. PubMed ID: 11361450
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.
    Monforte V; Román A; Gavaldà J; Bravo C; Gispert P; Pahissa A; Morell F
    Transplant Proc; 2005 Nov; 37(9):4039-42. PubMed ID: 16386621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
    Vrtovec B; Thomas CD; Radovancevic R; Frazier OH; Radovancevic B
    J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
    Thomas LD; Milstone AP; Miller GG; Loyd JE; Stephen Dummer J
    Clin Transplant; 2009; 23(4):476-83. PubMed ID: 19453645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation.
    Gerna G; Lilleri D; Callegaro A; Goglio A; Cortese S; Stroppa P; Torre G
    Transplantation; 2008 Jul; 86(1):163-6. PubMed ID: 18622294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ganciclovir shows benefit for prevention of CMV disease in liver transplant recipients.
    J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):43-4. PubMed ID: 11363747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.
    Doyle AM; Warburton KM; Goral S; Blumberg E; Grossman RA; Bloom RD
    Transplantation; 2006 Apr; 81(8):1106-11. PubMed ID: 16641594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis for cytomegalovirus in pancreas transplant recipients using intravenous ganciclovir.
    Kohli V; Velosa J; Sterioff S; Munn SR
    Transplant Proc; 1995 Dec; 27(6):2993. PubMed ID: 8539806
    [No Abstract]   [Full Text] [Related]  

  • 15. Ganciclovir therapy in an immunocompetent child with resistant fever and hepatosplenomegaly due to cytomegalovirus infection. Who and when to treat?
    Tezer H; Devrim I; Kara A; Cengiz AB; Seçmeer G
    Int J Infect Dis; 2008 May; 12(3):340-2. PubMed ID: 18023387
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Szer J; Durrant S; Schwarer AP; Bradstock KF; Gibson J; Arthur C; To LB; Hughes T; Raunow H
    Intern Med J; 2004 Mar; 34(3):98-101. PubMed ID: 15030456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.
    Razonable RR; van Cruijsen H; Brown RA; Wilson JA; Harmsen WS; Wiesner RH; Smith TF; Paya CV
    J Infect Dis; 2003 Jun; 187(11):1801-8. PubMed ID: 12751039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM; Subramaniam S
    Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus prophylaxis with IV ganciclovir in lung transplant recipients: the long and the short of it!
    Orens JB
    Chest; 1999 Nov; 116(5):1152-3. PubMed ID: 10559066
    [No Abstract]   [Full Text] [Related]  

  • 20. Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir?
    de la Cámara R; Fernández-Rañada JM
    J Infect Dis; 1999 Aug; 180(2):571-4. PubMed ID: 10395887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.